These in vivo results strongly suggest that the inhibitory effect of TET on breast cancer metastasis may be at least in part mediated by inhibiting tumor angiogenesis factors (VEGF and HIF-1α) or regulating adhesion factors (Integrin β5, ESM-1, and ICAM-1), although further investigation is required. The gene discussed is ICAM1; the disease is neoplasm.